The Board is remanding the case to obtain additional medical records and provide a de novo review of the record, including seeking an opinion on whether rheumatic heart disease contributed to the Veteran's death.
The deciding factor: The Board found that the RO failed to properly evaluate the lay evidence of record and did not attempt to obtain all available VA treatment records. The case is being remanded for further development.
- Claimed conditions
- rheumatic heart disease
- How they argued it
- Direct service connection
- Exposure basis
- None
- Rating assigned
- None in this decision
- Decision date
- September 19, 2011
- Citation
- 1135018
This is a plain-language summary generated by AI from a public Board of Veterans’ Appeals decision. It can contain errors — always verify against the original. Look up the original decision on VA.gov (opens in a new tab) using citation 1135018.
What this means for you
A remand is not a loss. The Board sent the case back for more development — often a new exam or missing records — before making a final decision. Many remands later end in a grant, and the decision spells out exactly what the Board wanted to see.
What you can do next
Related decisions
Other Board decisions on a similar condition or argued the same way.
- Partly granted
The veteran's claim for service connection for rheumatic heart disease was granted. The claim for hypertensive vascular disease was remanded.
- Remanded (sent back)
The Board has remanded the claims for service connection for glaucoma, Parkinson's disease, and dementia due to potential TERA exposure. The rating for bilateral hearing loss is also being remanded.
- Denied
The Veteran's claims for an earlier effective date prior to November 2, 2017, and higher ratings for his heart disability and bilateral knee disabilities have been denied. The Board found that the earliest possible effective date is November 2, 2017, when VA received the claim after final disallowance. For the knee disabilities, the evidence did not show limitation of flexion to less than 30 degrees or more exacerbations per year.
- Granted
The Veteran's rheumatic heart disease with coronary artery disease, status post stent placement is rated at 60 percent effective April 20, 2023.
Free starter guide for your own claim
Reading this because you were denied or under-rated? Get the plain-English next steps — your appeal options, the deadline that protects you, and how appeals like yours turn out. One email, no spam.
We will only use this to send the guide. No spam, unsubscribe any time. We never sell your information.
We are not the VA. Veterans’ Rights is an independent resource built for veterans. We are not the U.S. Department of Veterans Affairs, not part of the government, and not endorsed by any government agency.
This is general information, not legal advice. For advice about your own situation, talk to a VA-accredited representative — many help for free.